Cyberonics Launches VNS Therapy in Korea and Brazil

Cyberonics has received approval from the regulatory agencies in Korea and Brazil to market the VNS Therapy Models 102 and 102R Generators, and the VNS Therapy Model 302 Leads in Korea and Brazil for the treatment of pharmacoresistant epilepsy.

The Models 102 and 102R Generators are slimmer, lighter and easier to implant than their predecessor, the Model 101 Generator. The Model 102R Generator is a dual connector version of the Model 102 Generator for use as a replacement for Model 100 and 101 Generators with dual connector Model 300 leads that have reached end of service.

"These approvals provide improved commercial access to our patented VNS Therapy Systems for the safe and effective treatment of medically refractory epilepsy in Korea and Brazil," commented Michael Cheney, Cyberonics' vice president of marketing. "We have already received sales orders for these newly approved products and plan immediate shipment into these markets."